about
Monitoring laboratory data across manufacturers and laboratories--A prerequisite to make "Big Data" work.Chemical pathology and the new contract for GPs.Comparison of estimated glomerular filtration rate with routine creatinine clearance using a kinetic alkaline picrate assay from Olympus Diagnostica.Implications of method specific creatinine adjustments on General Medical Services chronic kidney disease classification.HDL-cholesterol and triglycerides: an overlooked issue?Maternal Blood Lipid Profile during Pregnancy and Associations with Child Adiposity: Findings from the ROLO Study.Best practice in primary care pathology: review 10.How to use difference plots in quantitative method comparison studies.True or not: uncertainty of laboratory results.How to use linear regression and correlation in quantitative method comparison studies.How Useful are Laboratory Practice Guidelines?Mitigation and detection of spurious potassium and sodium results.Why are clinical practice guidelines not followed?Analytical performance specifications for external quality assessment - definitions and descriptions.Hydroxyvitamin D assays: An historical perspective from DEQAS.Copper:caeruloplasmin ratio.Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practiceAdjusting copper concentrations for caeruloplasmin levels in routine clinical practice.Independent specimens are important.Limitations of transferability of absolute cut-points in non-standardised assays.Maternal and fetal blood lipid concentrations during pregnancy differ by maternal body mass index: findings from the ROLO study.Care is needed when using serum sodium levels to predict survival for patients with advanced liver disease.Optimal age for starting lipid lowering treatment. A 10 year risk of 30% should be used.Analysis of cerebrospinal fluid for suspected subarachnoid haemorrhage is improved by built-in spectrophotometer software.Limitations of non-ceruloplasmin-bound copper in routine clinical practice.The casino of life.Reflective testing.Unreliability of triglyceride measurement to predict turbidity induced interference.Estimated glomerular filtration rate needs UK consensus.The relationship between gonadotrophic hormones and progesterone in the mid-luteal phase.Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetes.Accuracy of cardiovascular risk estimation.Relationship of the absolute difference between direct and indirect ion selective electrode measurement of serum sodium and the total protein concentration.Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers.Targeted versus global approaches to the management of hypercholesterolaemia.Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus.Average serum triglyceride concentration in relation to day of the week in Burton-on-Trent.ABC dont ever forget glucose.Screening for cardiovascular disease.The copper/caeruloplasmin ratio in routine clinical practice in different laboratories.
P50
Q30909856-8E81943B-51A5-4FC9-AA49-809B9C5B937FQ35588072-3DF8140E-77B8-439E-859C-1CF294578DD0Q35954274-BA818D8F-EE65-4504-8BDF-B98E67498D8AQ35984421-859ECA3E-8393-4A47-A54C-817D41731AA4Q35984552-8F73B979-D47E-4BA4-B06F-D605A4993F34Q36112865-34B859C7-7CC3-4ABB-B25A-06F1BE743D5CQ36172237-3002FE50-CD1B-4A94-913C-5F580D880B69Q36421130-00266914-C811-45D8-928E-8538F8EFA6DFQ36641757-452A6151-85E7-450B-B34B-7002E1A009F3Q37103952-0ED06100-190C-47C0-97F7-3B013ACEB1A4Q37155329-C050B781-2DF9-44E7-AFB5-B600D5AA07D1Q37783641-16BF1D1D-6ED2-4F59-831C-35826408E80EQ38663773-6AD9CD7F-3552-48C2-AF02-68967A870450Q38736841-ECFAC63D-489A-43B4-9521-6D9805603C9BQ39452293-36F9BADA-93AE-4214-AC09-FC89C9C80C68Q41134452-C356896A-F9E1-43AD-ADA2-0AFF2E972C04Q41881822-D2E3BF49-729F-4301-AA0C-1A6C6F8A0D04Q42013144-EA970141-6BD5-4877-BF09-F0739ACA7226Q42337148-8E32EC71-E2E9-4508-9BC5-CB6F67762F22Q42339405-2814E876-196A-4AC0-A849-F96E7EAC9686Q42690557-26EF67DB-1E25-4373-905B-FBFC9FB11BFBQ42735882-DD19781E-D783-4598-B3AC-908F127E9D1FQ42768115-99BE249C-549D-43BD-B343-BFB8F0708BF9Q42835373-A67070FD-5676-4AE1-A24F-482A6B223E16Q42843644-E678D31B-A586-49EB-9350-94145C711EDDQ43010795-AA6B0735-2FFB-4B0C-A649-C7BDF864164DQ43010799-A720BD83-B816-40CB-AD71-CBFCE0B9DB21Q43010928-1BE69FC6-AF59-42AD-8679-474AE210F9D6Q43256489-D7A20522-B1FC-42D6-AC99-9A5B168CB229Q43260785-7DF0597C-0855-41EA-A5D7-7F8163A6D509Q44190238-53C76700-A8C4-4B7F-A4C0-DA6AA9B7D58CQ44372168-2BBDDFFB-B182-491E-97D0-1E1B8ADF7943Q44637643-6A73FDD3-CF9A-4F77-99B3-8D2B8C95FA74Q44840222-CF5328B3-701A-40CB-ADDC-A6547B75CC80Q44983323-950514CF-6275-4848-BFB0-976094F4A23FQ45068322-2C8495DE-11D9-4010-B81D-B30692A7F385Q45949318-F66B2E24-9C5E-461E-AC12-84145E0AF373Q46055774-BFBE6BAB-7AC0-4E73-8186-BC90EE035FDFQ46107862-43725706-16A7-4EE9-A995-81CAAD8435DCQ46110533-704BA559-A34F-4E1D-922F-2B70E1D3122A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Patrick J Twomey
@ast
Patrick J Twomey
@en
Patrick J Twomey
@es
Patrick J Twomey
@nl
Patrick J Twomey
@sl
type
label
Patrick J Twomey
@ast
Patrick J Twomey
@en
Patrick J Twomey
@es
Patrick J Twomey
@nl
Patrick J Twomey
@sl
altLabel
Pat Twomey
@en
Patrick Joseph Twomey
@en
Patrick Twomey
@en
prefLabel
Patrick J Twomey
@ast
Patrick J Twomey
@en
Patrick J Twomey
@es
Patrick J Twomey
@nl
Patrick J Twomey
@sl
P106
P21
P31
P496
0000-0001-7284-4673